Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q1 2014 · 10-Q
Revenue$85.67M$85.67M+14.2% vs Q1 2013 Net Income$27.43M$27.43M+6.9% vs Q1 2013 EPS Diluted$0.74$0.74+5.7% vs Q1 2013 Gross Profit$61,114,000+10.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flow$32,585,000+11.4% Free Cash Flowderived$28,774,000+7.6% Margins · derivedGross margin71.3%−2.7 pt vs Q1 2013
Operating margin46.0%−4.4 pt vs Q1 2013
Net margin32.0%−2.2 pt vs Q1 2013
ended Sep 30, 2013 · filed Nov 12, 2013 · 43 d after period end